Dual Compartment vs. Single Compartment Steroid Injection for de Quervain Disease .
Is a Steroid Injection in Both Compartments More Effective than an Injection in the Extensor Pollicis Brevis Subcompartment Alone in Patients with de Quervain Disease? A Randomized, Controlled Trial.
Clin Orthop Relat Res. 2022 Apr 1;480(4): 762-770.50 patients with de Quervain disease were randomized to receive a steroid injection into the extensor pollicis brevis subcompartment only (n=25) or into both the abductor pollicis longus and extensor pollicis brevis subcompartments (n=25). The outcomes of interest included pain on a Visual Analog Scale (VAS) and the incidence of injection-related complications. Results revealed no significant differences in VAS pain scores between the two groups up to 12 weeks follow up. The incidence of skin hypopigmentation was significantly lower in the single-compartment injection group vs. the dual-compartment injection group.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
0 of 4 monthly FREE articles unlocked
